High-risk patient factors include active gastrointestinal symptoms (odds ratio 7.66, 95% confidence interval 3.4217.17), early treatment phase (less than 4 weeks), higher medication doses, pre-existing diabetic gastroparesis, obesity (BMI greater than 30), and gastroesophageal reflux disease [31]
Jaiswal M, Martin CL, Brown MB, Callaghan B, Albers JW, Feldman EL, et al
Redheads: Detangling the Myths, Dental Update, 51 , 8, (557-560), (2024)
Ueda P, Wintzell V, Melbye M, et al
Prescription Weight Loss is excited to announce the launch of their innovative weight loss injection program, featuring cutting-edge treatments such as Semaglutide, Tirzepatide, NAD+, B12, and Sermorelin
The loss of vertical dimension has been associated with angular cheilitis in older individuals with an increase in facial laxity